HAP Trading’s Insmed INSM Stock Holding History

HAP Trading’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-130,000	Closed	-$2.79K	–	792
2024 Q4	$2.79K	Hold	130,000	–	–	﹤0.01%	680
2024 Q3	$17.8K	Buy	130,000 +10,000	+8%	+$738K	﹤0.01%	563
2024 Q2	$96K	Buy	+120,000	New	+$4.65M	0.01%	372

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

HAP Trading's INSM Position: Q1 2025 in Review

HAP Trading sold out of Insmed (INSM) in Q1 2025, closing a stake of 87,533 shares — an estimated $6.04M sold.

HAP Trading first reported a position in INSM in Q1 2024 and held it in 3 quarters. The position peaked at $6.09M in Q3 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

HAP Trading reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
HAP Trading sold 87,533 Insmed shares in Q1 2025, an estimated $6.04M.
HAP Trading first reported a position in Insmed in Q1 2024 and held it in 3 quarters.
HAP Trading's Insmed position peaked at $6.09M in Q3 2024.
441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on HAP Trading's 13F filing for Q1 2025, filed 14 May 2025.